Prevalence of complications and clinical audit of management of type 2 diabetes mellitus: A prospective hospital based study

Journal of Clinical and Diagnostic Research

Volumn 9, Issue 11, 2015, Pages OC25-OC28

  Kulshrestha, Malini ^a   Seth, Seema ^a   Tripathi, Ashutosh ^a   Seth, Anindita ^a   Kumar, Anoop ^a  

^a ROHILKHAND MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Diabetes care; Macrovascular complications; Management goals; Microvascular complications

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ABDOMINAL OBESITY; ADULT; AGE; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; FOLLOW UP; GANGRENE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MIDDLE AGED; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROSPECTIVE STUDY; RETINOPATHY; SYSTOLIC BLOOD PRESSURE;

EID: 84946550916     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2015/15369.6848     Document Type: Article

References (23)

1. American Diabetes Association. Standards of medical care in Diabetes. Diabetes Care. 2014; 37 (Suppl-1): 14-80.
2. Indian Council of Medical Research. Targets for control of DM in Guidelines for Management of Type 2 Diabetes. ICMR. New Delhi. 2005.
3. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321: 405–12.
4. Gaede P, Vedel P, Larsen N, Jensen GV, Parving H H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348 (5): 383-93.
5. Resnick H, Bardsley J, Foster GL, Ratner R E. Achievement of American Diabetic Association Clinical practice recommendations amongst US adult with diabetes 1999- 2002. Diabetes Care. 2006; 29: 531-37.
6. Fox K M, Gerber R A, Bolinder B, Chen J, Kumar S. Prevalence of glycaemic control amongst patient with type 2 Diabetics in United Kingdom general practice data base: a series of retrospective analysis of data from1998 to 2002. Clinical Therapeutics. 2006; 28(3): 388-94 .
7. Chuang L M, Tsai ST, Huang B Y, Tai T Y. The status of diabetes control in Asia-A cross sectional survey of 24317 patients with diabetes mellitus in 1998. Diabet Med. 2002; 19(12): 978-85.
8. Trinder, P. Determination of glucose in blood using glucose oxidase with an alternative oxygen receptor. Ann. Clin. Biochem. 1969; 6:24–27.
9. Jeppsson JO, Kobold U, Barr, J, Finke, A et. al. Approved IFFC reference method for measurement of HbA1c in human blood. Clin. Chem Lab Med. 2002; 40(1):78-89.
10. Allian CC, Poon, LS, Chan, CSG, Richmond, W, Fu, PC. Enzymatic determination of total serum cholesterol. Clin Chem clin biochem. 1974; 20(4):470-75.
11. McGowan MW, Artiss JD, Stranberg DR, Zak B. A Peroxidase coupled methodfor the colorimetric determination of serum Triglycerides. Clin. Chem. 1983: 29(3), 538-42.
12. Pisani T, Gebski CP, Leary E, et al. Accurate direct determination of Low density lipoprotein cholesterol assay. Arch Pathol Lab Med. 1995;119(12):1127-35.
13. Raheja BS, Kapur A, Bhoraskar A, Sathe SR. DiabCare Asia--India Study: diabetes care in India--current status. J Assoc Physicians India. 2001; 49: 717-22.
14. Nagpal J, Bhartia A. Quality of diabetes care in the middle- and high-income group populace – the Delhi Diabetes Community (DEDICOM) survey. Diabetes Care. 2006;29(11):2341–48.
15. Björk S, Kapur A, King H, Nair J, Ramachandran A. Global Policy: aspects of diabetes in India. Health Policy. 2003;66(1):61-72.
16. Gomes M B, Giandella D, Faria M. Prevalence of Type 2 Diabetic patients within the targets of care guidelines in daily clinical practice: A multicentre study in Brazil. Rev Diabetic Studies. 2006; 3: 82-87.
17. Kosachunhanun N, Benjasutrawong Y, Monkolsomlit S, Rawdaree P, Plengdhya N, Leelawatana R et al. Thailand diabetic registry project: Glycaemic control in Thai type 2 diabetics and its relation to hypoglycemic agents usage. J Med Assoc Thailand. 2006; 89 (Suppl):S66-71.
18. Mahmood K, Aamir A H. Glycemic control status in patients with type 2 diabetes. J Coll Physicians Surg Pak. 2005; 15(6): 323-25.
19. Menon A S, Ahluwalia A I. The ABC of Diabetes. How many patients are able to achieve the goal laid down by American Diabetes Association? Med Journal of Armed Forces. 2015;71: 132-34.
20. Bryant W, Greenfield J R, Chisholm D J, Campbell L V. Diabetes guidelines: easier to preach than to practise? Med J Aust. 2006; 185 (6): 305-09.
21. Mithal A, Majhi D, Shunmugavelu M, Talwarkar PG, Vasnawala H, Raza AS. Prevalence of dyslipidemia in adult Indian diabetic patients: A cross sectional study (SOLID). Indian J Endocrinol Metab. 2014; 18 (5): 642-47.
22. Deepa D V, Kiran B R, Gadwalkar Srikant R. Macrovascular and microvascular complication in newly diagnosed Type 2 Diabetes Mellitus. Indian J Clin Pract. 2014; 25 (7): 644-48.
23. Kumar H K, Kota S, Basile A, Modi K. Profile of microvascular disease in type 2 diabetes in a tertiary health care hospital in India. Ann Med Health Sci Res. 2012; 2 (2): 103-08.